Free Trial
NASDAQ:TLIS

Talis Biomedical 3/28/2024 Earnings Report

Talis Biomedical logo
$1.60 0.00 (0.00%)
As of 05/2/2025

Talis Biomedical EPS Results

Actual EPS
-$7.39
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Talis Biomedical Revenue Results

Actual Revenue
$0.20 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Talis Biomedical Announcement Details

Quarter
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Talis Biomedical's next earnings date is estimated for Tuesday, May 6, 2025, based on past reporting schedules.

Conference Call Resources

Talis Biomedical Earnings Headlines

Talis Biomedical Corp Ordinary Shares
Shocking AI play that’s beats Nvidia by a country mile
You’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is about to announce could change the AI market once again. Experts already predict the total addressable market could climb past $20 trillion. But Sykes believes most investors have missed what’s coming next. He’s tracking a new shift — and says the biggest gains are still ahead.
See More Talis Biomedical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Talis Biomedical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Talis Biomedical and other key companies, straight to your email.

About Talis Biomedical

Talis Biomedical (NASDAQ:TLIS) operates as a molecular diagnostic company, focusing on developing medical devices for infectious diseases and other conditions at the point of care in the United States. Talis Biomedical Corporation was incorporated in 2013 and is headquartered in Chicago, Illinois.

View Talis Biomedical Profile

More Earnings Resources from MarketBeat